The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
Top Cited Papers
- 23 December 2011
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 35 (6), 871-882
- https://doi.org/10.1016/j.immuni.2011.09.021
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Widespread Expression of Arginase I in Mouse Tissues: Biochemical and Physiological ImplicationsJournal of Histochemistry & Cytochemistry, 2003
- Dynamic programming of CD8+ T lymphocyte responsesNature Immunology, 2003
- A Noninvasive Genetic/Pharmacologic Strategy for Visualizing Cell Morphology and Clonal Relationships in the MouseJournal of Neuroscience, 2003
- Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1The EMBO Journal, 2002
- The CD28 Signaling Pathway Regulates Glucose MetabolismImmunity, 2002
- c-Myc regulates mammalian body size by controlling cell number but not cell sizeNature, 2001
- Signaling Takes a Breath – New Quantitative Perspectives on Bioenergetics and Signal TransductionImmunity, 2001
- Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted MutationImmunity, 2001
- Glutamine metabolism in endothelial cells: ornithine synthesis from glutamine via pyrroline-5-carboxylate synthaseComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2000
- Activation changes the spectrum but not the diversity of genes expressed by T cellsProceedings of the National Academy of Sciences of the United States of America, 1999